Pharmaceutical composition for curing diabetic retina pathological changes and method of preparing the same

A technology for retinopathy and diabetes, which is applied in the field of compositions for treating diabetic retinopathy and its preparation, and can solve problems such as unfavorable production quality control, improvement of drug efficacy, and low purity of arctiin
CN101273994AInactive Publication Date: 2008-10-01THE SECOND AFFILIATED HOSPITAL ARMY MEDICAL UNIV

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
THE SECOND AFFILIATED HOSPITAL ARMY MEDICAL UNIV
Publication Date
2008-10-01
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a composition containing 50 to 99 parts by weight of arctiin with the purity of more than 90 percent or 1 to 50 parts by weight of arctigenin and a preparation method thereof, and the functions of the composition are the treatment and the prevention of diabetic retinopathy. In the invention, by extracting the arctiin and the arctigenin, the pharmacological, toxicological and clinical trial results show that the composition of arctiin or arctigenin of the invention has the advantages of strong treatment effect and small toxicity and side effects in the treatment of the diabetic retinopathy.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a pharmaceutical composition with plant material extract as an active ingredient, in particular to a group of compositions for treating diabetic retinopathy and a preparation method thereof. Background technique

[0002] At present, the incidence of diabetes in the world is about 4.6%, with a total of 200 million people. Its incidence rate is increasing year by year. It is estimated that by 2025, the incidence rate of diabetes will be about 5.4%, reaching 300 million people.

[0003] Diabetic retinopathy (DR) is the most common and serious eye complication in diabetic patients, and it is one of the three major blinding diseases in the world. The rate of diabetic patients with retinopathy in my country is as high as 47% (the international average level is 45%). Diabetic retinopathy has no obvious eye symptoms in the early stage of the disease. As the disease progresses, vision loss or sudden drop may occur, and severe cases ma...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More